Aglaia BioMedical Ventures

Sapreme Technologies is a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutic.

InteRNA Technologies provides drug discovery and development services.

Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.

MIMETAS develops organ-on-a-chip tissue- and disease models for better, more reliable, and tailored medicines.

Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.

Cristal Therapeutics is a pharmaceutical company developing a new class of nanomedicine based on its proprietary polymeric technologies.

Macrophage Pharma is a immune-oncology company

InteRNA Technologies provides drug discovery and development services.

Inthera Bioscience is focused on developing inhibitors of intracellular protein interactions employing a proprietary technology platform.

Merus is a biomedical company engaged in the discovery and development of antibody-based biopharmaceuticals.